Viridian reports Q2 2026 results as Lumvoa launch begins in the U.S.Aug 6Quarterly updateveligrotugViridian Therapeutics, Inc.\DE
FDA approves Viridian's Lumvoa for thyroid eye diseaseJun 26Regulatory decisionveligrotugViridian Therapeutics, Inc.\DE
Sign in